PricewaterhouseCoopers (01358) issued a profit warning. Profit attributable to shareholders is expected to be reduced by 80% to 70% over the same period last year from 13 million yuan to 20 million yuan

According to the Zhitong Finance App, PricewaterhouseCoopers (01358) announced that it is expected that the Group will (i) obtain net profit of between RMB 32 million and RMB 49 million in the six months ended June 30, 2026, a decrease of 63% to 43% compared to approximately RMB 86.6 million for the six months ended June 30, 2025; and (ii) obtain profit attributable to the owners of the Company in the six months ended June 30, 2026, between RMB 13 million and RMB 20 million, compared with approximately 6 months ended June 30, 2025 RMB 66 million was reduced by 80% to 70%. This decrease is mainly due to the sharp drop in product prices in the infusion set business sector due to the almost full implementation of centralized volume procurement policies and covering Beijing and other regions, which account for a high share of sales in this sector, which in turn has led to a significant drop in sales revenue and gross margin.